Waldron Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Waldron Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$681K	Sell	11,814 -766	-6%	-$44K	0.02%	189
2026 Q1	$763K	Buy	12,580 +785	+7%	+$45.8K	0.03%	172
2025 Q4	$636K	Sell	11,795 -148	-1%	-$7.12K	0.03%	184
2025 Q3	$539K	Hold	11,943	–	–	0.02%	195
2025 Q2	$553K	Sell	11,943 -412	-3%	-$20.2K	0.02%	183
2025 Q1	$754K	Sell	12,355 -16,143	-57%	-$941K	0.04%	155
2024 Q4	$1.61M	Buy	28,498 +15,770	+124%	+$881K	0.06%	126
2024 Q3	$659K	Sell	12,728 -998	-7%	-$46.8K	0.03%	219
2024 Q2	$570K	Buy	13,726 +159	+1%	+$7.12K	0.03%	211
2024 Q1	$736K	Sell	13,567 -284	-2%	-$14.5K	0.03%	194
2023 Q4	$711K	Sell	13,851 -3,995	-22%	-$210K	0.03%	191
2023 Q3	$1.04M	Buy	17,846 +3,032	+20%	+$186K	0.05%	148
2023 Q2	$947K	Sell	14,814 -8,107	-35%	-$544K	0.05%	157
2023 Q1	$1.59M	Buy	22,921 +3,405	+17%	+$240K	0.08%	125
2022 Q4	$1.39M	Hold	19,516	–	–	0.09%	125
2022 Q3	$1.39M	Buy	19,516 +146	+0.8%	+$10.6K	0.09%	125
2022 Q2	$1.49M	Buy	19,370 +1,449	+8%	+$110K	0.08%	131
2022 Q1	$1.31M	Buy	17,921 +1,074	+6%	+$72.1K	0.07%	148
2021 Q4	$1.05M	Sell	16,847 -1,624	-9%	-$95.3K	0.05%	174
2021 Q3	$1.09M	Sell	18,471 -1,210	-6%	-$79.7K	0.06%	143
2021 Q2	$1.31M	Buy	19,681 +5,958	+43%	+$388K	0.08%	120
2021 Q1	$866K	Sell	13,723 -836	-6%	-$52K	0.06%	139
2020 Q4	$903K	Sell	14,559 -540	-4%	-$33.2K	0.07%	134
2020 Q3	$910K	Sell	15,099 -135	-0.9%	-$8.13K	0.08%	125
2020 Q2	$895K	Sell	15,234 -4,448	-23%	-$266K	0.08%	115
2020 Q1	$1.1M	Buy	19,682 +6,272	+47%	+$383K	0.12%	101
2019 Q4	$860K	Buy	13,410 +6,586	+97%	+$377K	0.08%	123
2019 Q3	$346K	Buy	6,824 +69	+1%	+$3.24K	0.04%	173
2019 Q2	$306K	Sell	6,755 -537	-7%	-$25K	0.03%	178
2019 Q1	$347K	Buy	7,292 +3,254	+81%	+$162K	0.04%	172
2018 Q4	$209K	Buy	+4,038	New	+$217K	0.03%	197
2018 Q2	–	Sell	-3,493	Closed	-$220K	–	178
2018 Q1	$220K	Sell	3,493 -325	-9%	-$20.9K	0.05%	152
2017 Q4	$233K	Hold	3,818	–	–	0.05%	142
2017 Q3	$243K	Buy	+3,818	New	+$223K	0.07%	127
2017 Q2	–	Sell	-8,749	Closed	-$475K	–	147
2017 Q1	$475K	Buy	+8,749	New	+$480K	0.12%	110
2016 Q4	–	Sell	-4,267	Closed	-$230K	–	141
2016 Q3	$230K	Sell	4,267 -166	-4%	-$10.7K	0.08%	122
2016 Q2	$326K	Buy	4,433 +207	+5%	+$14.6K	0.12%	88
2016 Q1	$269K	Buy	4,226 +150	+4%	+$9.46K	0.1%	111
2015 Q4	$280K	Buy	4,076 +11	+0.3%	+$727	0.1%	112
2015 Q3	$240K	Buy	+4,065	New	+$258K	0.1%	109

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Waldron Private Wealth's BMY Position: Q2 2026 in Review

Waldron Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 6.1% in Q2 2026, selling an estimated $44K and leaving 11,814 shares worth $681K. The position accounts for 0.02% of the portfolio, ranked #189.

Waldron Private Wealth first reported a position in BMY in Q3 2015 and has held it in 40 quarters since. The position peaked at $1.61M in Q4 2024. 964 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Waldron Private Wealth held 11,814 shares of Bristol-Myers Squibb worth $681K as of Q2 2026.
Waldron Private Wealth sold 766 Bristol-Myers Squibb shares in Q2 2026, an estimated $44K.
Bristol-Myers Squibb made up 0.02% of Waldron Private Wealth's portfolio in Q2 2026, its #189 holding.
Waldron Private Wealth first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 40 quarters since.
Waldron Private Wealth's Bristol-Myers Squibb position peaked at $1.61M in Q4 2024.
964 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.